drugset / Trial / NCT01511770

Bioavailability Study of Fluconazole Tablets 200 mg Under Fasting Conditions

NCT01511770

Phase 1 Completed 17 enrolled Dr. Reddy's Laboratories Limited
RandomizedCrossoverOpen-labelTreatment

Summary

The objective of this study was an open-label, randomized, 2-way crossover to compare the single-dose relative bioavailability of Dr. Reddy's Laboratories, Ltd. and Pfizer (Diflucan®) 200 mg fluconazole tablets under fasting conditions.

Timeline

Start
2002-08
Primary completion
2002-08
Completion
2002-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fluconazole Small molecule 200 mg Oral

Indications

No indication recorded.